AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26418369 — intervention group
Group type: EXPERIMENTAL
Intervention: HMB supplementation with HIIT (S)
Number of subjects: 37
Study 26418369 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo with HIIT (P)
Number of subjects: 37
Study 26418369 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 37
Study 24396060 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose dopamine (2 μg kg(‐1) min(‐1))
Number of subjects: 11
Study 24396060 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 11
Study 22442733 — intervention group
Group type: EXPERIMENTAL
Intervention: Active gameplay of Re-Mission videogame
Number of subjects: 0
Study 22442733 — intervention group
Group type: COMPARATOR
Intervention: Passive exposure to gameplay audio-visual stream
Number of subjects: 0
Study 19129422 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD7009 30-minute 3.25 mg/min
Number of subjects: 168
Study 19129422 — intervention group
Group type: COMPARATOR
Intervention: AZD7009 15-minute 3.25 mg/min
Number of subjects: 168
Study 19129422 — intervention group
Group type: COMPARATOR
Intervention: AZD7009 15-minute 4.4 mg/min
Number of subjects: 168
Study 19129422 — intervention group
Group type: COMPARATOR
Intervention: Placebo (combined)
Number of subjects: 168
Study 19129422 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD7009 30-minute 3.25 mg/min (AF episodes <=30 days)
Number of subjects: 168
Study 19129422 — intervention group
Group type: COMPARATOR
Intervention: Placebo followed by DC cardioversion (AF episodes <=30 days)
Number of subjects: 168
Study 19129422 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD7009 best-dose group
Number of subjects: 168
Study 17645251 — intervention group
Group type: EXPERIMENTAL
Intervention: BA plus scalp acupuncture (SA) group (B group)
Number of subjects: 152
Study 17645251 — intervention group
Group type: EXPERIMENTAL
Intervention: BA plus abdominal acupuncture (AA) group (C group)
Number of subjects: 152
Study 17645251 — intervention group
Group type: EXPERIMENTAL
Intervention: BA plus SA plus AA group (D group)
Number of subjects: 152
Study 17645251 — intervention group
Group type: COMPARATOR
Intervention: Body acupuncture (BA) group (A group)
Number of subjects: 152
Study 15734231 — intervention group
Group type: EXPERIMENTAL
Intervention: Active 2mg nicotine lozenge
Number of subjects: 917
Study 15734231 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 917
Study 12190711 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention program including collaborative treatment plan, monthly telephone monitoring by a nurse care manager, feedback of monitoring results, algorithm-based medication recommendations, outreach and care coordination, structured psychoeducational group program (Life Goals Program).
Number of subjects: 441
Study 12190711 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 441
Study 9855417 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9855417 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine
Number of subjects: 0
Study 7814823 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (10 mg oral dose)
Number of subjects: 28
Study 7814823 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil (1 mg i.v. administered 5 days before baseline)
Number of subjects: 28
Study 2815976 — intervention group
Group type: EXPERIMENTAL
Intervention: Purified chick embryo cell (PCEC) rabies vaccine
Number of subjects: 0
Study 2815976 — intervention group
Group type: COMPARATOR
Intervention: Human diploid cell rabies vaccine (HDCV)
Number of subjects: 0
Study 1090337 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (200 mu g)
Number of subjects: 16
Study 1090337 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (40 mu g)
Number of subjects: 16
Study 1090337 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of salbutamol and ipratropium bromide
Number of subjects: 16
Study 1090337 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 31741992 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral glossopharyngeal nerve block with bupivacaine
Number of subjects: 64
Study 31741992 — intervention group
Group type: COMPARATOR
Intervention: No glossopharyngeal nerve block
Number of subjects: 64
Study 28166501 — intervention group
Group type: EXPERIMENTAL
Intervention: Sniff-controlled self-activated FES
Number of subjects: 14
Study 28166501 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver activated FES
Number of subjects: 14
Study 28166501 — intervention group
Group type: EXPERIMENTAL
Intervention: Button self-activated FES
Number of subjects: 14
Study 28166501 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual assistance of a caregiver
Number of subjects: 14
Study 28166501 — intervention group
Group type: COMPARATOR
Intervention: All assisted methods
Number of subjects: 14
Study 27189595 — intervention group
Group type: EXPERIMENTAL
Intervention: FENO-based asthma management (adjusted inhaled corticosteroid dose based on FENO levels)
Number of subjects: 600
Study 27189595 — intervention group
Group type: COMPARATOR
Intervention: Usual care (one clinical assessment of asthma, self-management education, treatment changes by general practitioner)
Number of subjects: 600
Study 27189595 — intervention group
Group type: EXPERIMENTAL
Intervention: FENO-based asthma management
Number of subjects: 600
Study 27189595 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 600
Study 23692321 — intervention group
Group type: EXPERIMENTAL
Intervention: Carisbamate 400 mg/day
Number of subjects: 614
Study 23692321 — intervention group
Group type: EXPERIMENTAL
Intervention: Carisbamate 800 mg/day
Number of subjects: 614
Study 23692321 — intervention group
Group type: EXPERIMENTAL
Intervention: Carisbamate 1200 mg/day
Number of subjects: 614
Study 23692321 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 300 mg/day
Number of subjects: 614
Study 23692321 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 614
Study 23692321 — intervention group
Group type: EXPERIMENTAL
Intervention: Dizziness (adverse event)
Number of subjects: 614
Study 21968546 — intervention group
Group type: EXPERIMENTAL
Intervention: Flow rate adjusted to heart rate (Group 1: dosage/16)
Number of subjects: 296
Study 21968546 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed flow rate (Group 3)
Number of subjects: 296
Study 21968546 — intervention group
Group type: COMPARATOR
Intervention: Flow rate based on scan time + 8 (Group 2)
Number of subjects: 296
Study 19535468 — intervention group
Group type: EXPERIMENTAL
Intervention: Improvisational music therapy
Number of subjects: 10
Study 19535468 — intervention group
Group type: COMPARATOR
Intervention: Toy play sessions
Number of subjects: 10
Study 17475962 — intervention group
Group type: EXPERIMENTAL
Intervention: (18)F-FDG PET studies at 1 and 3 weeks after chemotherapy initiation
Number of subjects: 16
Study 17475962 — intervention group
Group type: EXPERIMENTAL
Intervention: (18)F-FDG PET studies
Number of subjects: 16
Study 15727386 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX)
Number of subjects: 20
Study 15727386 — intervention group
Group type: COMPARATOR
Intervention: Control (no PTX)
Number of subjects: 20
Study 12548530 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone (low-dose, alternate-day)
Number of subjects: 8
Study 12548530 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 8
Study 12548530 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 8
Study 10588224 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose enalapril (40 mg daily)
Number of subjects: 75
Study 10588224 — intervention group
Group type: COMPARATOR
Intervention: Low-dose enalapril (5 mg daily)
Number of subjects: 75
Study 8942297 — intervention group
Group type: EXPERIMENTAL
Intervention: Tripotassium dicitrato bismuthate (240 mg b.i.d.), metronidazole (250 mg t.i.d.), and amoxicillin (500 mg t.i.d.) for 14 days (Group 1)
Number of subjects: 180
Study 8942297 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg b.i.d.) and amoxicillin (1000 mg b.i.d.) for 14 days (Group 2)
Number of subjects: 180
Study 8942297 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg b.i.d.), metronidazole (250 mg t.i.d.), and amoxicillin (500 mg t.i.d.) for 14 days (Group 3)
Number of subjects: 180
Study 8942297 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg q.d.) and amoxicillin (500 mg t.i.d.) for 14 days followed by tripotassium dicitrato bismuthate (240 mg b.i.d.) and nizatidine (150 mg q.d.) for 14 days (Group 4)
Number of subjects: 180
Study 1944902 — intervention group
Group type: EXPERIMENTAL
Intervention: Trihexyphenidyl
Number of subjects: 10
Study 1944902 — intervention group
Group type: EXPERIMENTAL
Intervention: Tridihexethyl chloride
Number of subjects: 10
Study 7068113 — intervention group
Group type: EXPERIMENTAL
Intervention: chenodeoxycholic acid (CDCA) 375 or 750 mg g.d. for 2 years
Number of subjects: 126
Study 7068113 — intervention group
Group type: EXPERIMENTAL
Intervention: chenodeoxycholic acid (CDCA)
Number of subjects: 126
Study 30804311 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotary Kedo-S files
Number of subjects: 75
Study 30804311 — intervention group
Group type: COMPARATOR
Intervention: Hand K-files
Number of subjects: 75
Study 30804311 — intervention group
Group type: COMPARATOR
Intervention: H-files
Number of subjects: 75
Study 29238184 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroid treatment
Number of subjects: 13591
Study 29238184 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline pulmonary maintenance medication
Number of subjects: 13591
Study 29238184 — intervention group
Group type: COMPARATOR
Intervention: No specific intervention mentioned
Number of subjects: 13591
Study 27084659 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton therapy (arm A)
Number of subjects: 92
Study 27084659 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon ion therapy (arm B)
Number of subjects: 92
Study 27084659 — intervention group
Group type: COMPARATOR
Intervention: Both therapies (Proton and Carbon ion)
Number of subjects: 92
Study 25149894 — intervention group
Group type: EXPERIMENTAL
Intervention: Baru almonds supplementation (20 g/day)
Number of subjects: 20
Study 25149894 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1 corn starch capsule/day)
Number of subjects: 20
Study 22573845 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple ARV (zidovudine, lamivudine, and lopinavir/ritonavir during pregnancy and breastfeeding)
Number of subjects: 824
Study 22573845 — intervention group
Group type: COMPARATOR
Intervention: AZT/sdNVP (zidovudine until delivery with single-dose nevirapine without postpartum prophylaxis)
Number of subjects: 824
Study 22573845 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple ARV
Number of subjects: 824
Study 22573845 — intervention group
Group type: COMPARATOR
Intervention: AZT/sdNVP
Number of subjects: 824
Study 19509551 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus vitamin B6 PC6 points injection
Number of subjects: 142
Study 19509551 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture
Number of subjects: 142
Study 19509551 — intervention group
Group type: COMPARATOR
Intervention: Vitamin B6 alone
Number of subjects: 142
Study 17484670 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term psychodynamic psychotherapy based on supportive-expressive therapy, tailored for social phobia.
Number of subjects: 0
Study 17484670 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 0
Study 16080084 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-delivered partner treatment (PDPT)
Number of subjects: 977
Study 16080084 — intervention group
Group type: EXPERIMENTAL
Intervention: Booklet-enhanced partner referral (BEPR)
Number of subjects: 977
Study 16080084 — intervention group
Group type: COMPARATOR
Intervention: Standard partner referral (PR)
Number of subjects: 977
Study 12504971 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate pushing
Number of subjects: 170
Study 12504971 — intervention group
Group type: COMPARATOR
Intervention: Delayed pushing
Number of subjects: 170
Study 9164180 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtotal lymphoid irradiation (STLI)
Number of subjects: 78
Study 9164180 — intervention group
Group type: COMPARATOR
Intervention: Vinblastine, methotrexate, and bleomycin (VBM) chemotherapy and regional radiotherapy
Number of subjects: 78
Study 8428718 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (0.15 mg/kg intravenously)
Number of subjects: 0
Study 8428718 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3618714 — intervention group
Group type: EXPERIMENTAL
Intervention: Tono-Pen tonometer
Number of subjects: 270
Study 3618714 — intervention group
Group type: COMPARATOR
Intervention: Goldmann tonometer
Number of subjects: 270
Study 31783741 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor knowledge of menstruation
Number of subjects: 791
Study 31783741 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of absorbent materials
Number of subjects: 791
Study 31783741 — intervention group
Group type: EXPERIMENTAL
Intervention: Cleaning external genitalia
Number of subjects: 791
Study 31783741 — intervention group
Group type: EXPERIMENTAL
Intervention: Menstrual hygienic practice
Number of subjects: 791
Study 31783741 — intervention group
Group type: EXPERIMENTAL
Intervention: Age less than 15 years
Number of subjects: 791
Study 31783741 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer days of menstrual flow
Number of subjects: 791
Study 31783741 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor knowledge of menses
Number of subjects: 791
Study 28958328 — intervention group
Group type: EXPERIMENTAL
Intervention: DDD-CLS pacing for 12 months
Number of subjects: 46
Study 28958328 — intervention group
Group type: COMPARATOR
Intervention: Sham DDI mode for 12 months
Number of subjects: 46
Study 28958328 — intervention group
Group type: EXPERIMENTAL
Intervention: DDD-CLS pacing
Number of subjects: 46
Study 28958328 — intervention group
Group type: COMPARATOR
Intervention: Sham DDI mode
Number of subjects: 46
Study 27537387 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG-IUS
Number of subjects: 153
Study 27537387 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg oral medroxyprogesterone acetate (MPA) for 10 days per cycle
Number of subjects: 153
Study 27537387 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg oral MPA daily for 6 months
Number of subjects: 153
Study 27537387 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in intracellular bodies
Number of subjects: 153
Study 24852952 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic offer for a relative to witness CPR
Number of subjects: 570
Study 24852952 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional practice)
Number of subjects: 570
Study 21945889 — intervention group
Group type: EXPERIMENTAL
Intervention: HEARTY exercise intervention (a combination of healthy eating, aerobic, and resistance exercise)
Number of subjects: 44
Study 18721830 — intervention group
Group type: EXPERIMENTAL
Intervention: Contour present but not perceived
Number of subjects: 0
Study 18721830 — intervention group
Group type: COMPARATOR
Intervention: Contour absent (no contour)
Number of subjects: 0
Study 18721830 — intervention group
Group type: EXPERIMENTAL
Intervention: Contour present and perceived
Number of subjects: 0
Study 18721830 — intervention group
Group type: COMPARATOR
Intervention: Contour not detected
Number of subjects: 0
Study 17895895 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG supplementation (1-2 x 10(10) per day)
Number of subjects: 150
Study 17895895 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified de Gramont regimen
Number of subjects: 150
Study 17895895 — intervention group
Group type: COMPARATOR
Intervention: Mayo regimen
Number of subjects: 150
Study 17895895 — intervention group
Group type: EXPERIMENTAL
Intervention: Guar gum supplementation (11 g per day)
Number of subjects: 150
Study 15118279 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum total cholesterol concentration during follow-up
Number of subjects: 4349
Study 15118279 — intervention group
Group type: EXPERIMENTAL
Intervention: High concentrations of serum HDL cholesterol
Number of subjects: 4349
Study 15118279 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes mellitus
Number of subjects: 4349
Study 15118279 — intervention group
Group type: COMPARATOR
Intervention: Hypertension and smoking
Number of subjects: 4349
Study 11396814 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride (0.2 mg/kg dose three times daily)
Number of subjects: 49
Study 11396814 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 9757196 — intervention group
Group type: EXPERIMENTAL
Intervention: Epirubicin (30-40 mg)
Number of subjects: 26
Study 9757196 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitoxantrone (6-8 mg)
Number of subjects: 26
Study 8140875 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine
Number of subjects: 9
Study 8140875 — intervention group
Group type: COMPARATOR
Intervention: Epidural bupivacaine
Number of subjects: 9
Study 3061042 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 times 10 Gy afterloading therapy combined with 45 Gy percutaneous telecobalt therapy
Number of subjects: 0
Study 3061042 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 times 8 Gy afterloading therapy combined with 45 Gy percutaneous telecobalt therapy
Number of subjects: 0
Study 3061042 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 times 5 Gy afterloading therapy combined with 45 Gy percutaneous telecobalt therapy
Number of subjects: 0
Study 1467634 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (1.2 mg sublingually)
Number of subjects: 40
Study 1467634 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (10 mg capsule, chewed and swallowed)
Number of subjects: 40
Study 151547 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (40 microgram four times a day)
Number of subjects: 21
Study 151547 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (200 microgram four times daily)
Number of subjects: 21
Study 151547 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide and Salbutamol together
Number of subjects: 21
Study 151547 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (10 mg three times daily) in addition to both drugs
Number of subjects: 21
Study 30450642 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg/kg 4MP (fomepizole)
Number of subjects: 6
Study 30450642 — intervention group
Group type: COMPARATOR
Intervention: Intravenous placebo
Number of subjects: 6
Study 28303422 — intervention group
Group type: COMPARATOR
Intervention: Fun For Wellness (FFW) intervention
Number of subjects: 479
Study 26501387 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% N2O
Number of subjects: 7112
Study 24314223 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with vinorelbine plus cisplatin (NP)
Number of subjects: 146
Study 24314223 — intervention group
Group type: COMPARATOR
Intervention: Induction chemotherapy with docetaxel plus cisplatin (TP)
Number of subjects: 146
Study 21821818 — intervention group
Group type: EXPERIMENTAL
Intervention: Camelina meal
Number of subjects: 204
Study 21821818 — intervention group
Group type: COMPARATOR
Intervention: Control (50% ground corn and 50% soybean meal)
Number of subjects: 204
Study 21821818 — intervention group
Group type: COMPARATOR
Intervention: Crude glycerin (50% soybean meal, 33% ground corn, 15% crude glycerin, 2% corn gluten meal)
Number of subjects: 204
Study 21821818 — intervention group
Group type: COMPARATOR
Intervention: Crude glycerin
Number of subjects: 204
Study 19768640 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol (100/6 microg) once daily plus additional doses as needed (SMART)
Number of subjects: 102
Study 19768640 — intervention group
Group type: COMPARATOR
Intervention: Control group treated according to guidelines (medium daily doses of ICS plus SABA if needed)
Number of subjects: 102
Study 16732085 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 20
Study 16732085 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 20
Study 15107933 — intervention group
Group type: EXPERIMENTAL
Intervention: Fuzzy model
Number of subjects: 153
Study 15107933 — intervention group
Group type: COMPARATOR
Intervention: Multi-discriminant analysis (MDA)
Number of subjects: 153
Study 15107933 — intervention group
Group type: COMPARATOR
Intervention: Both methods (MDA and fuzzy)
Number of subjects: 153
Study 11718986 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumescent technique with subdermal injections of epinephrine, thrombin spray, and warm saline soaked laparotomy pads.
Number of subjects: 20
Study 11718986 — intervention group
Group type: COMPARATOR
Intervention: Thrombin spray and warm saline soaked laparotomy pads (control group).
Number of subjects: 20
Study 9812659 — intervention group
Group type: EXPERIMENTAL
Intervention: Caihu Qingxin Yin (CHQXY)
Number of subjects: 52
Study 9812659 — intervention group
Group type: COMPARATOR
Intervention: Routine method using energy mixture
Number of subjects: 52
Study 8124407 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine/Caffeine combination (20 mg/200 mg) three times a day
Number of subjects: 127
Study 8124407 — intervention group
Group type: COMPARATOR
Intervention: Ephedrine alone (20 mg) three times a day
Number of subjects: 127
Study 8124407 — intervention group
Group type: COMPARATOR
Intervention: Caffeine alone (200 mg) three times a day
Number of subjects: 127
Study 3306439 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxaprotiline (150 mg daily for 28 days)
Number of subjects: 38
Study 3306439 — intervention group
Group type: COMPARATOR
Intervention: Clomipramine (150 mg daily for 28 days)
Number of subjects: 38
Study 3306439 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxaprotiline
Number of subjects: 38
Study 3306439 — intervention group
Group type: COMPARATOR
Intervention: Clomipramine
Number of subjects: 38
Study 30926992 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-biofortified beans (86.1 ppm iron)
Number of subjects: 55
Study 30926992 — intervention group
Group type: COMPARATOR
Intervention: Comparison beans (50.1 ppm iron)
Number of subjects: 55
Study 28165812 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid emulsion (LE)
Number of subjects: 0
Study 28165812 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine (Bup1000)
Number of subjects: 0